- PsyBio Therapeutics Corp. (PSYB) has closed the second tranche of a non-brokered private placement
- Under the second tranche, the company issued 5,533,785 for gross proceeds of $276,689
- Together with the first tranche, the company has raised gross proceeds of $909,970
- PsyBio Therapeutics is an intellectual property-driven biotechnology company
- Psybio Therapeutics Corp. (PSYB) opened trading at C$0.07
PsyBio Therapeutics Corp. (PSYB) has closed the second tranche of a non-brokered private placement.
Under the second tranche, the company issued 5,533,785 units priced at $0.05 per unit for gross proceeds of $276,689. Together with the first tranche, the company has raised gross proceeds of $909,970.
Each unit consists of one subordinate voting share and one common share purchase warrant exercisable at $0.10 per share for 24 months.
Warrants are subject to an acceleration clause.
All securities issued are subject to a statutory four-month hold period.
PsyBio Therapeutics is an intellectual property-driven biotechnology company developing psycho-targeted therapeutics to improve mental health and neurological conditions.
Psybio Therapeutics Corp. (PSYB) opened trading at C$0.07.